Skip to main content
Clinical Trials/NCT00921479
NCT00921479
Recruiting
Not Applicable

Postoperative Course and Quality of Life Following Surgical Removal of the Mandibular 3. Molar

Ullevaal University Hospital2 sites in 1 country300 target enrollmentJune 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain, Postoperative
Sponsor
Ullevaal University Hospital
Enrollment
300
Locations
2
Primary Endpoint
Oral Health Impact Profile (OHIP-14)
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to determine how quality of life changes after surgical removal of wisdom teeth

Detailed Description

A significant percentage of patients are subjected to surgical removal of 3. molars every year. The surgical mucosal and osseous procedure may lead to postoperative discomfort including pain, for the patient. Information with respect to how patients regard the impact of this surgical treatment on oral health including pain and swelling is of great interest. More precise information about the postoperative course following this surgery will be beneficial in improving clinical treatment procedures with respect to alleviating the patients' postoperative period.

Registry
clinicaltrials.gov
Start Date
June 2005
End Date
December 31, 2024
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Ullevaal University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Lasse Ansgar Skoglund

Professor

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients of either sex of Caucasian origin, between the age of 18 and 45, who are candidates for surgical removal of one mandibular

Exclusion Criteria

  • Chronic drug treatment (except birth control medication) with analgesics, anti-inflammatory treatment (both steroidal (SAIDs) and non-steroidal anti-inflammatory drugs (NSAIDs)) apart from standard postoperative analgesic treatment administered by the operator.
  • The necessity for anti-microbial drugs.
  • Pregnant or lactating women.
  • Patients with diabetes.
  • Patients who due to age or communication skills are considered unable to complete patient forms.
  • Professional evaluation suggests an alteration of the planned surgical area or treatment form.
  • Surgery exceeding 45 minutes, from time of first incision to completed suturing.
  • Known or assumed intolerance or hypersensibility to ibuprofen (standard postoperative analgesic treatment).
  • Known or assumed intolerance or hypersensibility to the standard local anaesthetic Xylocain-adrenalin (lidocaine-adrenalin).
  • Consumption of alcohol in the period from 2 days before or until the end of the primary observation period (postoperative days 0-7.

Outcomes

Primary Outcomes

Oral Health Impact Profile (OHIP-14)

Time Frame: 7 days

Measure functional status of the oral cavity

Secondary Outcomes

  • Norwegian Translated Short-Form McGill Pain Questionnaire (NTSF-MPQ)(7 days)
  • Corahs Dental Anxiety Scale (CDAS)(1 day)
  • Pain Intensity (0-10 Numerical Rating Scale)(7 days)
  • Norwegian McGill Pain Questionnaire (NMPQ)(7 days)
  • Subjective Swelling Assessment (0-10 Numerical rating Scale)(7 Days)

Study Sites (2)

Loading locations...

Similar Trials